Omeros Gets EMA CHMP Negative Opinion On Narsoplimab In TA‑TMA; Co. To Request Re‑Examination And Seek Ad Hoc Expert Group Review

Loading news article.

Omeros Gets EMA CHMP Negative Opinion On Narsoplimab In TA‑TMA; Co. To Request Re‑Examination And Seek Ad Hoc Expert Group Review | WAPE

Article summary